ICMR

No company has been awarded the tender yet, and it is currently under evaluation

According to WHO, monkeypox is a viral zoonosis – a virus transmitted to humans from animals – with symptoms similar to smallpox…

The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were observed…

The study was conducted in January and the findings were published in the "Journal of Travel Medicine" on 24th March

The ICMR has spent around Rs 35 crores in research and development of Covaxin

The revised guidelines continue to recommend Emergency Use Authorisation (EUA) or off-label use of Remdesivir in patients with…

Dr Bhargava had last week said that Molnupiravir has major safety concerns. He added that WHO and the UK have not included it for…

The latest study assessed 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, from 15th April…

According to sources, the booster dose issue is likely to be discussed in the next meeting of the National Technical Advisory…

The Lancet peer-review confirms the efficacy analysis which demonstrates Covaxin to be effective against COVID-19